Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 4 , Pages 323-326, Winter 2009

Sentinel Node and Positron Emission Tomography Mapping in Lung Cancer

  • Chukwumere Nwogu, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Chukwumere Nwogu, MD, Department of Thoracic Surgery, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263

Department of Surgery, University at Buffalo, SUNY; Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, New York

Radioguided lymph node mapping can potentially improve staging in locoregional non-small cell lung cancer. This is accomplished by using advanced pathologic techniques to detect micrometastases in selected thoracic lymph nodes. The use of isosulfan blue, technetium-99m and 18F-fluorodeoxyglucose (FDG) as mapping agents have been reported. Despite several limitations in this technique, it may facilitate the selection of patients for novel therapies, resulting in improved outcomes for lung cancer patients.

Keywords: lung cancer, lymph nodes, metastasis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1043-0679(09)00140-3

doi:10.1053/j.semtcvs.2009.11.004

Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 4 , Pages 323-326, Winter 2009

Article Tools